Perrigo reported $-27.5M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
AbbVie USD 4.22B 605M Sep/2026
Abbott USD 920M 8M Sep/2026
Bayer EUR -672M 891M Sep/2026
Bristol-Myers Squibb USD 2.16B 1.16B Sep/2026
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Corcept Therapeutics USD 124.49M 82.35M Sep/2026
Dr.Reddys Laboratories INR 9.25B 4.81B Sep/2026
Eli Lilly USD 7.1B 301M Jun/2026
J&J USD 210M 5.32B Sep/2026
Merck USD 5.07B 6.4B Sep/2026
Nestle CHF 3.47B 496M Jun/2026
Perrigo USD -27.5M 102M Sep/2026
Pfizer USD 3.24B 3.49B Sep/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 38.54M 15.39M Jun/2026
Reckitt Benckiser GBP 284M 287M Dec/2024
Sanofi EUR 3.02B 2.68B Sep/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Teva Pharmaceutical Industries USD 233M 809M Sep/2026
Xeris Pharmaceuticals USD -31.1M 33.34M Jun/2026
Zoetis USD 591M 100M Sep/2026